Don Erb was Director of Isotope Production and Distribution at the U.S. Department of Energy and held many other positions in the Atomic Energy Commission and the DOE. He initiated the recommendation in the 2010 letter to the Science Advisor to the White House for the U.S. to take an active role in the domestic production of radioisotopes for nuclear medicine. The government claimed it was working on that, but without fast reactors, domestic isotope production has not progressed sufficiently. The government needs to change its policies toward fast reactors and spent fuel reprocessing. His recommendation however did lead to the efforts for global public education on this topic at Go Nuclear, Inc. and Environmentalists for Nuclear - USA. His pioneering efforts along with many other distinguished scientists and engineers led to the tremendous accomplishments in the field of peaceful use of nuclear energy.
Nuclear Africa, Kelvin Kemm: What is nuclear medicine? Nuclear medicine involves the application of radioactive substances to people, in both the diagnosis and the treatment of disease. In nuclear medicine procedures, radioisotopes are combined with other chemicals or pharmaceutical compounds to form radiopharmaceuticals. They migrate through the body and localise in specific organs or cellular receptors. This property provides nuclear medicine with the ability to image the extent of a disease process in the body, based on the cellular function and physiology, rather than relying only on physical changes in the tissue anatomy.
International Atomic Energy Agency, IAEA: This is the May, 2010 review of worldwide production and supply of molybdenum 99, which is extremely important in diagnostic nuclear medicine. In February, 2010 a letter was sent to the Office of Science and Technology Policy, The White House recommending that the United States focus on domestic production of molybdenum 99. The reply was that they were working on it. One member of the team working on it was positive and thought the problem would be solved with the renewed efforts. Scientists who worked on production of radioisotopes in American reactors were not optimistic about the renewed efforts. In 2016, an American medical professional said that he didn't think he would see satisfactory domestic production of this very important isotope in his life time. Thus is the government progress in the USA.
Assessing non-reactor based isotope production through examining Canada’s recent decision to shift towards particle accelerator generation of its major medical radioisotopes and similar initiatives around the world, including Belgium and Germany;